April 19, 2018 / 12:13 PM / 3 months ago

BRIEF-Takeda Says Shire Rejected Revised Proposal of 46.50 Pounds Per Share

April 19 (Reuters) - TAKEDA PHARMACEUTICAL CO LTD:

* TAKEDA - TAKEDA WAS NOTIFIED THAT BOARD OF SHIRE HAD REJECTED ITS PROPOSAL

* TAKEDA PHARMACEUTICAL CO LTD - TAKEDA STATEMENT REGARDING SHIRE PLC

* TAKEDA PHARMACEUTICAL CO LTD - CONFIRMS THAT ON APRIL 12 IT MADE A REVISED PROPOSAL TO BOARD OF SHIRE

* TAKEDA - DISCUSSIONS BETWEEN PARTIES REGARDING A POTENTIAL OFFER ARE ONGOING

* TAKEDA PHARMACEUTICAL CO LTD - REVISED PROPOSAL TO BOARD OF SHIRE TO ACQUIRE SHARE CAPITAL OF SHIRE FOR A PRICE EQUIVALENT TO £46.50 PER SHARE

* TAKEDA PHARMACEUTICAL CO LTD - REVISED PROPOSAL TO BOARD OF SHIRE COMPRISED OF £17.75 IN CASH (TO BE PAID IN US$) AND £28.75 OF NEW TAKEDA SHARES.

* TAKEDA - PROPOSAL DOES NOT CONSTITUTE AN OFFER OR IMPOSE ANY OBLIGATION ON TAKEDA TO MAKE AN OFFER, NOR DOES IT EVIDENCE A FIRM INTENTION TO MAKE AN OFFER

* TAKEDA PHARMACEUTICAL CO LTD - TAKEDA INTENDS TO MAINTAIN ITS WELL-ESTABLISHED DIVIDEND POLICY AND INVESTMENT GRADE CREDIT RATING

* TAKEDA - TAKEDA WAS SUBSEQUENTLY NOTIFIED THAT BOARD OF SHIRE HAD REJECTED ITS PROPOSAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below